The new version of the National Reimbursement Drug List has been implemented; the newly added drug, telaprotein injection, already has sales records.
On January 1, 2026, the new Basic Medical Insurance Drug List and the Commercial Insurance Innovative Drug List officially took effect. The new Basic Medical Insurance Drug List includes 114 newly added drugs, while the Commercial Insurance Innovative Drug List includes 19 drugs. From January 1 to January 6, 2026, many insured individuals have already purchased the newly added drugs from these medical institutions. For example, sales records for telbropod injection have been recorded at 1,433 medical institutions, and sales records for inxulan sodium injection have been recorded at 400 medical institutions. (CCTV News)
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
WTWOOL Coin Trading Guide: Understanding How to Buy and Sell Wolf Town Wool Tokens and Their Exchange Listings
-
2
BNB is priced at approximately $705, down over 60% from its all-time high. What is its long-term value outlook?
-
3
OneKey founder Yishi warns: Some older iPhone models have unfixable chip vulnerabilities, endangering seed phrase storage security.
-
4
XRP Long/Short Critical Point: The Battle to Defend the $1.30 Support and the Resurgence of ETF Expectations
-
5
How to Get Ethereum: A Guide to Buying, Staking, and Secure Storage
-
6
CIPHC: Current Status and Market Analysis of Cipher Core Token
-
7
EBEN Token: Green Ben Token Analysis and Market Status
-
8
SHKG (Shikage) Analysis: Current Status of Rug-Pull Prevention Liquidity Locking Project
-
9
A List of Major Global Bitcoin Exchanges
-
10
Pi Network Mainnet Status and Latest Official News Analysis
Markets Today
Recommended Reading







